glp-1 antagonists Agonists: A Comprehensive Overview JCI Insight - Antagonizing somatostatin

Federal law prohibits Medicare from covering drugs solely for weight loss, meaning GLP-1s are only reimbursed under Part D for other approved indications, like type 2 diabetes, cardiovascular risk reduction, MASH, or sleep apnea

If you are a competitive athlete in a tested sport, discuss this with your provider before starting any peptide therapy

For a researcher, that means you can order it without a prescription as a research-use-only product

Front Endocrinol (Lausanne) (2011) 2:102

Mechanism involves NO system modulation (homeostatic regulationupregulating when deficient, moderating when excessive), VEGF/VEGFR2 upregulation for angiogenesis, FAK-paxillin pathway activation for cell migration (40% increase per Chang et al.), and EGR-1 transcription factor upregulation for growth factor sensitivity